Skip to main content
$186.03 -$2.02 (-1.1%)

04:00 PM EDT on 10/21/21

Medpace Holdings (NASDAQ:MEDP)

CAPS Rating: 3 out of 5

Current Price $186.03 Mkt Cap $6.7B
Open $187.76 P/E Ratio 37.95
Prev. Close $186.03 Div. (Yield) $0.00 (0.0%)
Daily Range $183.75 - $188.71 Volume 142,190
52-Wk Range $105.48 - $199.04 Avg. Daily Vol. 173,589

Caps

How do you think NASDAQ:MEDP will perform against the market?

Add Stock to CAPS Watchlist

All Players

49 Outperform
5 Underperform
 

All-Star Players

19 Outperform
2 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:MEDP Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:MEDP VS S&P 500 (SPY)

NASDAQ:MEDP Summary

Fools bullish on NASDAQ:MEDP are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about MEDP.

Recs

0
Member Avatar TMFjimhalley (< 20) Submitted: 5/17/2021 10:14:05 PM : Outperform Start Price: $163.28 NASDAQ:MEDP Score: +4.82

Clinical research organizations such as Medpace are seeing increased revenue because their expertise is particularly helpful to emerging pharmaceutical companies. The company has increasedits revenue 145% over the past three years and doesn't seem to be slowing down.

Recs

0
Member Avatar ProfitJim (56.31) Submitted: 5/5/2021 2:10:56 PM : Outperform Start Price: $164.03 NASDAQ:MEDP Score: +4.19

Good growth. Contract research org. Relatively low mkt cap in Life Sciences with large opp to grow. In the small and mid sized biopharma segment. Accelerating Revenue and Profitability over the past 3 years, along with strong EPS growth (over 50% CAGR for the past 3 years).

Recs

0
Member Avatar AlejandroOrtiz (89.55) Submitted: 2/20/2021 3:29:09 AM : Outperform Start Price: $164.29 NASDAQ:MEDP Score: -3.98

Debt free knowledgeable and long term leadership at the helm and there IPO in 2016 is proving to be an excellent opportunity for investors to own a company the has and will continue to make yearly gains for years to come.

Leaderboard

Find the members with the highest scoring picks in MEDP.

Score Leader

WasGibt

WasGibt (56.76) Score: +179.94

The Score Leader is the player with the highest score across all their picks in MEDP.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
WasGibt 56.76 11/1/2018 Outperform 5Y $52.01 +257.68% +67.44% +190.24 0 Comment
PaulNy 99.72 5/24/2019 Outperform 5Y $57.20 +225.23% +60.43% +164.80 0 Comment
ssinvplace < 20 2/19/2019 Outperform 3M $70.55 +163.69% +64.09% +99.59 0 Comment
TDogg 76.79 5/4/2020 Outperform 5Y $76.02 +144.70% +61.67% +83.03 0 Comment
sandvig 97.60 1/10/2020 Outperform 5Y $84.18 +120.99% +38.56% +82.42 0 Comment
Plasmidologist 94.27 8/23/2019 Outperform 5Y $79.70 +133.40% +58.82% +74.58 0 Comment
sublimeinvestor 89.85 8/23/2019 Outperform 5Y $79.70 +133.40% +58.82% +74.58 0 Comment
L8starter 81.30 4/29/2020 Outperform 5Y $82.08 +126.64% +55.17% +71.48 0 Comment
DaytradingStars 60.90 6/9/2020 Outperform 5Y $92.38 +101.37% +41.82% +59.56 0 Comment
snowman12345 76.26 4/27/2020 Outperform 5Y $85.12 +118.55% +59.09% +59.46 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for MEDP.